WeVote
Log In

Bill

Bill

HB 1444

Concerning rapid whole genome sequencing.

2025-2026 Regular Session Introduced by Steve Bergquist and 12 co-sponsors

HB 1444 establishes regulatory standards and clinical frameworks for rapid whole genome sequencing implementation in Washington healthcare settings.

Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
0
WeVote Research Nonpartisan
Bill Summary · HB 1444

Legislative bill overview

HB 1444 addresses the implementation and regulation of rapid whole genome sequencing (RWGS) technology in Washington State. The bill appears to establish frameworks for when and how this advanced genetic testing can be used, likely focusing on clinical applications, quality standards, and accessibility considerations.

Why is this important

Whole genome sequencing technology is advancing rapidly and becoming more affordable, creating opportunities for early disease detection and personalized medicine, but also raising questions about clinical validity, privacy, equity, and appropriate oversight. Clear state-level policy on RWGS can ensure patients benefit from innovation while protecting against misuse, ensuring equitable access, and maintaining data security.

Potential points of contention

  • Clinical validity and evidence standards: Disagreement over what level of scientific evidence should be required before RWGS is covered by insurance or recommended clinically, versus allowing broader experimental use
  • Privacy and genetic data protection: Concerns about how genomic data is stored, who can access it, data retention periods, and protections against discrimination or misuse by insurers and employers
  • Equity and access: Questions about whether RWGS will be available to all patients regardless of income/insurance status, or whether it becomes a premium service creating disparities in personalized medicine access

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.